Literature DB >> 16700888

CD4+CD25+ regulatory T cells in health and disease.

Haiying Liu1, Bernard P Leung.   

Abstract

1. Over the past 5 years, tremendous progress has been made in understanding the suppressive mechanisms of T regulatory (Treg) cells. The Treg cells, a subpopulation of T cells, have been shown to play an important role in maintaining peripheral tolerance and the prevention of autoimmunity. 2. Various populations of Treg cells have been described, including thymically derived CD4(+)CD25(+) Treg cells. These naturally occurring Treg cells are present in the periphery and are capable of suppressing proliferation and effector T cell responses both in vitro and in vivo. 3. In addition, a second subset of Treg cells, type 1 T regulatoary (Tr1) and Th3 cells, exert their suppressive capacity via cytokines such as interleukin-10 and transforming growth factor-beta and are contact independent. 4. The present review summarizes the characteristics and molecular basis of CD4(+)CD25(+) Treg cells, as well as their therapeutic potential in modulating inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16700888     DOI: 10.1111/j.1440-1681.2006.04401.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  23 in total

1.  Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat.

Authors:  Max Brenner; Teresina Laragione; Nuriza C Yarlett; Pércio S Gulko
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 2.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

3.  Efficient expansion of cryopreserved CD4(+)CD25(+)CD127(lo/-) cells in Type 1 diabetes.

Authors:  Anna Rydén; Maria Faresjö
Journal:  Results Immunol       Date:  2011-08-22

4.  Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases.

Authors:  Shuko Murakami; Yasumitsu Nishimura; Megumi Maeda; Naoko Kumagai; Hiroaki Hayashi; Ying Chen; Masayasu Kusaka; Takumi Kishimoto; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2009-03-18       Impact factor: 3.674

5.  Effects of low-dose-gamma rays on the immune system of different animal models of disease.

Authors:  Noriko Shimura; Shuji Kojima
Journal:  Dose Response       Date:  2014-04-23       Impact factor: 2.658

6.  Role of CD4CD25FOXP3 Regulatory T Cells in Psoriasis.

Authors:  Woo-Jin Yun; Deok-Woo Lee; Sung-Eun Chang; Ghil-Suk Yoon; Joo-Ryung Huh; Chong-Hyun Won; Mi-Woo Lee; Sung-Eun Kim; Beom-Joon Kim; Kee-Chan Moon; Jee-Ho Choi
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

Review 7.  Midkine and multiple sclerosis.

Authors:  Hideyuki Takeuchi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

8.  Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1.

Authors:  Urmila Maitra; Sarah Davis; Christopher M Reilly; Liwu Li
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 9.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

10.  Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity.

Authors:  Shyamesh Kumar; Joram J Buza; Shane C Burgess
Journal:  Cancer Microenviron       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.